A Modular Antigen Presenting Peptide/Oligonucleotide Nanostructure Platform for Inducing Potent Immune Response

Area of Science:

• Immunology
• Nanotechnology
• Vaccine Development

Background:

• Cellular immunity, particularly CD8+ T cells, is vital for combating cancers and viral infections.
• Current subunit vaccines face limitations in stimulating robust CD8+ T-cell responses.
• Covalent antigen-adjuvant conjugation shows limited success in enhancing CD8+ T-cell immunity.

Purpose of the Study:

• To develop a novel vaccine strategy that overcomes limitations in CD8+ T-cell stimulation.
• To demonstrate a modular nanosystem for efficient antigen presentation and immune response induction.
• To leverage noncovalent attachment for improved vaccine immunogenicity.

Main Methods:

• A modular system using noncovalent attachment of biotinylated antigen to a hybrid nanofiber.
• The nanofiber system comprises biotinylated self-assembling peptide and CpG oligodeoxynucleotides (ODN).
• Biotin-streptavidin interaction facilitates the attachment of antigen to the peptide/ODN hybrid nanosystem.

Main Results:

• The peptide/oligonucleotide hybrid nanosystems achieved exceptionally high CD8+ T-cell responses.
• Nanostructures triggered a strong IgG response and modulated antigen cross-presentation.
• The system enhanced antigen uptake and promoted antigen-presenting cell maturation.

Conclusions:

• The developed nanosystem offers a versatile, biocompatible, and biodegradable strategy for new vaccine development.
• It effectively bypasses limitations of traditional inactivated or live-attenuated virus vaccines.
• This approach represents an efficient strategy for enhancing CD8+ T-cell mediated immunity in vaccines.